These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1835389)

  • 1. Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.
    Clements PJ; Lachenbruch PA; Furst DE; Paulus HE; Sterz MG
    Arthritis Rheum; 1991 Nov; 34(11):1371-80. PubMed ID: 1835389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis.
    Clements PJ; Lachenbruch PA; Ng SC; Simmons M; Sterz M; Furst DE
    Arthritis Rheum; 1990 Aug; 33(8):1256-63. PubMed ID: 2390128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis in the elderly.
    Czirják L; Nagy Z; Szegedi G
    Clin Rheumatol; 1992 Dec; 11(4):483-5. PubMed ID: 1486736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac involvement in systemic sclerosis.
    Anvari A; Graninger W; Schneider B; Sochor H; Weber H; Schmidinger H
    Arthritis Rheum; 1992 Nov; 35(11):1356-61. PubMed ID: 1445453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
    Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
    Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis.
    Candell-Riera J; Armadans-Gil L; Simeón CP; Castell-Conesa J; Fonollosa-Pla V; García-del-Castillo H; Vaqué-Rafart J; Vilardell M; Soler-Soler J
    Arthritis Rheum; 1996 Jul; 39(7):1138-45. PubMed ID: 8670322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography.
    Morelli S; Sgreccia A; De Marzio P; Perrone C; Ferrante L; Gurgo AM; Gurgo di Castelmenardo AM; Aguglia G; De Vincentiis G; Scopinaro F; Calvieri S
    J Rheumatol; 1997 Dec; 24(12):2358-63. PubMed ID: 9415642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
    Becker M; Graf N; Sauter R; Allanore Y; Curram J; Denton CP; Khanna D; Matucci-Cerinic M; de Oliveira Pena J; Pope JE; Distler O; ;
    Ann Rheum Dis; 2019 Sep; 78(9):1242-1248. PubMed ID: 31227488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report).
    Foocharoen C; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Rheumatology (Oxford); 2015 Sep; 54(9):1616-21. PubMed ID: 25863044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac involvement in progressive systemic sclerosis (PSS)].
    Pinto S; Magherini A
    Boll Soc Ital Cardiol; 1981; 26(12):2097-9. PubMed ID: 6224498
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular manifestations in progressive systemic sclerosis].
    Badui E; Robles E; Hernández C; García Rubí D; Mintz G
    Arch Inst Cardiol Mex; 1985; 55(3):263-8. PubMed ID: 2932080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.
    Tashkin DP; Clements PJ; Wright RS; Gong H; Simmons MS; Lachenbruch PA; Furst DE
    Chest; 1994 Feb; 105(2):489-95. PubMed ID: 8306752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations.
    Savas N; Dagli U; Ertugrul E; Kuran S; Sahin B
    Dig Dis Sci; 2007 Nov; 52(11):3081-6. PubMed ID: 17393310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.